Article Text
PDFEditorial
Making the case for advance provision of mifepristone and misoprostol for abortion in the United States
Statistics from Altmetric.com
Footnotes
Twitter @K_Ehrenreich, @BiggsAntonia, @DrDGrossman
Correction notice This paper has been updated since it was first published. The funder name has been corrected.
Funding This study was funded by Fidelity Charitable.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.